Postmortem indices linking risk factors to cognition: Results from the Religious Order Study and the Memory and Aging Project

Alzheimer Disease and Associated Disorders

Volumn 20, Issue SUPPL. 2, 2006, Pages

  Bennett, David A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Pathology; Risk factors

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; AUTOPSY; BRAIN TISSUE; COGNITION; COGNITIVE DEFECT; DISEASE PREDISPOSITION; DISTRESS SYNDROME; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEMORY CONSOLIDATION; NEUROFIBRILLARY TANGLE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIGION; REVIEW; RISK FACTOR; SENILE PLAQUE; SHORT TERM MEMORY;

AGED; AGING; ALZHEIMER DISEASE; BRAIN; BRAIN INFARCTION; COGNITION DISORDERS; EDUCATIONAL STATUS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; RISK FACTORS;

EID: 33747613756     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200607001-00009     Document Type: Review

References (57)

1. Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer's disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119-1122.
2. Sloane PD, Zimmerman S, Suchindran C, et al. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health. 2002;23:213-231.
3. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337-1342.
4. Kukull WA, Larson EB, Reifler BV, et al. The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology. 1990;40:1364-1369.
5. Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol. 1994;51:888-895.
6. Gearing M, Mirra SS, Hedreen JC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology. 1995;45:461-466.
7. Morris JC, McKeel DW Jr, Fulling K, et al. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol. 1988;24:17-22.
8. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988;23:138-441.
9. Crystal HA, Dickson DW, Sliwinski MJ, et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol. 1993;34:566-573.
10. Knopman DS, Parisi JE, Salviati A, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol. 2003;62:1087-1095.
11. Schmitt FA, Davis DG, Wekstein DR, et al. "Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology. 2000;55:370-376.
12. Galvin JE, Powlishta KK, Wilkins K, et al. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Arch Neurol. 2005;62:758-765.
13. Riley KP, Snowdon DA, Markesbery WR. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol. 2002;51:567-577.
14. Hulette CM, Welsh-Bohmer KA, Murray MG, et al. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol. 1998;57:1168-1174.
15. Snowdon DA. Healthy aging and dementia: findings from the Nun Study. Ann Intern Med. 2003;139:450-454.
16. White L, Small BJ, Petrovitch H, et al. Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol. 2005;18:224-227.
17. Green MS, Kaye JA, Ball MJ. The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old. Neurology. 2000;54:105-113.
18. Troncoso JC, Martin LJ, Dal Forno G, et al. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging. 1996;17:365-371.
19. Naslund J, Haroutunian V, Mohs R, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 2000;283:1571-1577.
20. Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc. 1999;47:564-569.
21. Petrovitch H, Ross GW, Steinhorn SC, et al. AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol. 2005;57:98-103.
22. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging. 2002;17:179-193.
23. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198-205.
24. Wilson RS, Bienias JL, Evans DA, et al. The Religious Orders Study: overview and relation between change in cognitive and motor speed. Aging, Neuropsychol, Cogn. 2004;11:280-303.
25. Bennett DA, Schneider JA, Buchman AS, et al. The Rush Memory and Aging Project: Study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005;25:163-175.
26. Wilson RS, Barnes LL, Kreuger KR, et al. Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc. 2005;11:400-407.
27. Boyle PA, Wilson RS, Aggarwal NT, et al. Risk of Alzheimer's disease and rate of cognitive decline among persons with mild cognitive impairment. Neurology. 2006. In press.
28. Bennett DA, Schneider JA, Bienias JL, et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64:834-841.
29. Schneider JA, Wilson RS, Cochran EJ, et al. Relation of cerebral infarctions to dementia and cognitive function in older person. Neurology. 2003;60:1082-1089.
30. Bennett DA, Schneider JA, Wilson RS, et al. Neurofibrillary tangles mediate the association of amyloid load and with clinical Alzheimer's disease and level of cognitive function. Arch Neurol. 2004;61:378-384.
31. Bennett DA, Schneider JA, Arnold SE, et al. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol. 2006;5:406-412.
32. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based clinical-pathologic studies. Neurology. 2006;66:1837-1844.
33. Schneider JA, Li JL, Li Y, et al. Neurofibrillary tangles in the substantia nigra are related to gait impairment in older persons. Ann Neurol. 2006;59:166-173.
34. Schneider JA, Wilson RS, Bienias JL, et al. Cerebral infarctions and the likelihood of dementia from Alzheimer's disease pathology. Neurology. 2004;62:1148-1152.
35. Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS). Pathologic correlates of late onset dementia in a multicentre, community based population in England and Wales. Lancet. 2001;357:169-175.
36. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813-817.
37. Wilson RS, Schneider JA, Barnes LL, et al. Effect of apolipoprotein E ε4 allele status on decline in different cognitive systems and development of Alzheimer's disease over a 6-year period. Arch Neurol. 2002;59:1154-1160.
38. Wilson RS, Bienias JL, Berry-Kravis E, et al. The apolipoprotein E ε2 allele and decline in episodic memory. J Neurol, Neurosurg Psychiatry. 2002;73:672-677.
39. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E4 allele, Alzheimer's disease pathology, and the clinical expression of Alzheimer's disease. Neurology. 2003;60:246-252.
40. Bennett DA, Schneider JA, Wilson RS, et al. Amyloid mediates the association of apolipoprotein E ε4 to level of cognitive function in older persons. J Neurol Neurosurg Psychiatry. 2005;76:1194-1199.
41. Schneider JA, Bienias JL, Wilson RS, et al. Relation of the apolipoprotein E ε4 allele to cerebral infarction in older persons. Stroke. 2005;36:954-959.
42. Arvanitakis Z, Bienias JL, Wilson RS, et al. Diabetes and risk of Alzheimer's disease and decline in cognitive function. Arch Neurol. 2004;61:661-666.
43. Buchman AS, Wilson RS, Bienias JL, et al. Change in body mass index (BMI) and risk of incident Alzheimer's disease (AD). Neurology. 2005;65:892-897.
44. Shah RC, Wilson RS, Bienias JL, et al. Effect of blood pressure on incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology. 2005;25:30-36.
45. Arvanitakis Z, Wilson RS, Li Y, et al. Diabetes and function in different cognitive systems in older persons without dementia. Diabetes Care. 2006;29:560-565.
46. Wilson RS, Mendes de Leon CF, Barnes LL, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer's disease. JAMA. 2002;287:742-748.
47. Bennett DA, Wilson RS, Schneider JA, et al. Education modifies the relation of AD pathology to cognitive function in older persons. Neurology. 2003;60:1909-1915.
48. Bennett DA, Schneider JA, Wilson RS, et al. Education modifies the association of amyloid, but not tangles, with cognitive function. Neurology. 2005;65:953-955.
49. Wilson RS, Scherr PA, Hoganson G, et al. Early life socioeconomic status and late life risk of Alzheimer's disease. Neuroepidemiology. 2005;25:8-14.
50. Barnes LL, Wilson RS, Schneider JA, et al. Gender, cognitive decline and risk of AD in older persons. Neurology. 2003;60:1777-1781.
51. Barnes LL, Wilson RS, Schneider JA, et al. Sex differences in the clinical manifestations of Alzheimer's disease pathology. Arch Gen Psychiatry. 2005;62:685-691.
52. Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109:186-204.
53. Bassuk SS, Glass TA, Berkman LF. Social disengagement and incident cognitive decline in community-dwelling elderly persons. Ann Intern Med. 1999;131:165-173.
54. Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depression, change in cognitive function, and risk of Alzheimer's disease in older persons. Neurology. 2002;59:364-370.
55. Wilson RS, Schneider JA, Bienias JL, et al. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology. 2003;61:1102-1108.
56. Bennett DA, Wilson RS, Schneider JA, et al. Cerebral infarctions and the relation of depressive symptoms to level of cognitive function in older persons. Am J Geriatr Psychiatry. 2004;12:211-219.
57. Wilson RS, Evans DA, Bienias JL, et al. Proneness to psychological distress and risk of Alzheimer's disease. Neurology. 2003;61:1579-1585.